YU44788B - Process for making ready for use solution for injections containing antitumor antracyclic glicoside - Google Patents

Process for making ready for use solution for injections containing antitumor antracyclic glicoside

Info

Publication number
YU44788B
YU44788B YU1035/86A YU103586A YU44788B YU 44788 B YU44788 B YU 44788B YU 1035/86 A YU1035/86 A YU 1035/86A YU 103586 A YU103586 A YU 103586A YU 44788 B YU44788 B YU 44788B
Authority
YU
Yugoslavia
Prior art keywords
glicoside
antracyclic
use solution
injections containing
making ready
Prior art date
Application number
YU1035/86A
Other languages
English (en)
Other versions
YU103586A (en
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Ponti Roberto De
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU44788(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Priority to SI8611035A priority Critical patent/SI8611035A8/sl
Publication of YU103586A publication Critical patent/YU103586A/xx
Publication of YU44788B publication Critical patent/YU44788B/xx
Priority to HRP-1035/86A priority patent/HRP920525B1/xx
Priority to BA970187A priority patent/BA97187B1/bs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
YU1035/86A 1985-08-02 1986-06-16 Process for making ready for use solution for injections containing antitumor antracyclic glicoside YU44788B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SI8611035A SI8611035A8 (sl) 1985-08-02 1986-06-16 Postopek pripravljanja injekcijske raztopine, pripravljene za uporabo, ki vsebuje protitumorni, antraciklinski glikozid
HRP-1035/86A HRP920525B1 (en) 1985-08-02 1992-09-28 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
BA970187A BA97187B1 (bs) 1985-08-02 1997-08-14 Postupak za pravljenje rastvora za injekcije spremnog za koriscenje koji sadrzi antitumorni antraciklinski glikozid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519452A GB8519452D0 (en) 1985-08-02 1985-08-02 Injectable solutions

Publications (2)

Publication Number Publication Date
YU103586A YU103586A (en) 1988-04-30
YU44788B true YU44788B (en) 1991-02-28

Family

ID=10583216

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1035/86A YU44788B (en) 1985-08-02 1986-06-16 Process for making ready for use solution for injections containing antitumor antracyclic glicoside

Country Status (34)

Country Link
US (1) US4946831A (nl)
JP (1) JPH0655667B2 (nl)
KR (1) KR920001773B1 (nl)
CN (1) CN1064531C (nl)
AT (1) AT397463B (nl)
BE (1) BE905202A (nl)
BG (1) BG60425B2 (nl)
CA (1) CA1291037C (nl)
CH (2) CH690490C2 (nl)
CS (1) CS277561B6 (nl)
CY (1) CY1592A (nl)
DE (1) DE3621844C2 (nl)
DK (1) DK167557B1 (nl)
ES (1) ES8801580A1 (nl)
FI (1) FI86800C (nl)
FR (1) FR2585569B1 (nl)
GB (2) GB8519452D0 (nl)
GR (1) GR861556B (nl)
HK (1) HK93990A (nl)
HU (1) HU196123B (nl)
IE (1) IE59297B1 (nl)
IL (1) IL79129A (nl)
IT (1) IT1204906B (nl)
NL (2) NL191507C (nl)
NO (1) NO170913C (nl)
NZ (1) NZ216604A (nl)
PH (1) PH22332A (nl)
PT (1) PT82865B (nl)
RU (2) RU1837883C (nl)
SE (1) SE466383C (nl)
SG (1) SG80690G (nl)
UA (1) UA29383C2 (nl)
YU (1) YU44788B (nl)
ZA (1) ZA864792B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
BE1000540A5 (fr) * 1986-12-05 1989-01-24 Erba Carlo Spa Solutions injectables pretes a l'emploi contenant un agent antitumeur du type anthracycline-glucoside.
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
DE68905577T2 (de) * 1988-12-05 1993-07-01 Bristol Myers Squibb Co Doxorubicin-loesungen.
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
DE19544532C2 (de) * 1995-11-29 1997-12-11 Pharma Dynamics Gmbh Verfahren zum Herstellen eines Doxorubicin-Lyophilisats
PT848009E (pt) * 1996-12-16 2000-11-30 Pharmachemie Bv Processo para a preparacao de epirubicina ou seus sais de adicao de acido a partir de daunorubicina
DE69737510T2 (de) 1996-12-30 2007-12-06 Battelle Memorial Institute, Columbus Verwendung eines unverkapselten Antikrebs-Arzneimittels zur Herstellung einer Zubereitung zur Behandlung von Neoplasmen durch Inhalation
US20090253220A1 (en) * 2003-10-28 2009-10-08 Sukanta Banerjee Absorbing Biomolecules into Gel-Shell Beads
EP1814525A2 (en) * 2005-05-11 2007-08-08 Sicor Inc. Stable lyophilized anthracycline glycosides
JP6138140B2 (ja) * 2011-10-25 2017-05-31 ネクター セラピューティクス 癌患者の治療
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE2738656A1 (de) * 1977-08-26 1979-03-08 Microbial Chem Res Found Anthracyclinglycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2433027A1 (fr) * 1978-08-08 1980-03-07 Rhone Poulenc Ind Nouveau procede de preparation de derives de la doxorubicine
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
BE1000540A5 (fr) * 1986-12-05 1989-01-24 Erba Carlo Spa Solutions injectables pretes a l'emploi contenant un agent antitumeur du type anthracycline-glucoside.

Also Published As

Publication number Publication date
RU1837883C (ru) 1993-08-30
IT8620917A0 (it) 1986-06-26
NL191507C (nl) 2000-02-16
SE8602743D0 (sv) 1986-06-19
NO862587D0 (no) 1986-06-26
PH22332A (en) 1988-07-29
DK167557B1 (da) 1993-11-22
FI862629A0 (fi) 1986-06-19
IE59297B1 (en) 1994-02-09
GB2178311A (en) 1987-02-11
GB2178311B (en) 1989-10-11
IT1204906B (it) 1989-03-10
PT82865A (en) 1986-07-01
ZA864792B (en) 1988-02-24
SE466383B (sv) 1992-02-10
IL79129A0 (en) 1986-09-30
AT397463B (de) 1994-04-25
IL79129A (en) 1992-03-29
NL191507B (nl) 1995-04-18
NL8601698A (nl) 1987-03-02
DK306286D0 (da) 1986-06-27
FR2585569A1 (fr) 1987-02-06
DE3621844A1 (de) 1987-03-05
CA1291037C (en) 1991-10-22
SE466383C (sv) 1996-02-19
ATA176886A (de) 1993-09-15
SG80690G (en) 1990-11-23
CN1064531C (zh) 2001-04-18
NO170913C (no) 2003-10-10
GB8614800D0 (en) 1986-07-23
GR861556B (en) 1986-10-17
FI86800B (fi) 1992-07-15
BE905202A (fr) 1987-02-02
CH668911A5 (de) 1989-02-15
SE8602743L (sv) 1987-02-03
FR2585569B1 (fr) 1990-01-19
NO170913B (no) 1992-09-21
UA29383C2 (uk) 2000-11-15
CS470886A3 (en) 1992-11-18
NO862587L (no) 1987-02-03
PT82865B (pt) 1989-01-17
NL300011I1 (nl) 2000-10-02
CS277561B6 (en) 1993-03-17
CY1592A (en) 1992-04-03
HUT42326A (en) 1987-07-28
KR920001773B1 (ko) 1992-03-02
JPH0655667B2 (ja) 1994-07-27
NZ216604A (en) 1989-10-27
US4946831A (en) 1990-08-07
CH690490C2 (de) 2000-09-29
AU598197B2 (en) 1990-06-21
RU2110263C1 (ru) 1998-05-10
BG60425B2 (bg) 1995-03-31
DE3621844C2 (de) 1994-02-17
DK306286A (da) 1987-02-03
HU196123B (en) 1988-10-28
JPS6248629A (ja) 1987-03-03
HK93990A (en) 1990-11-23
FI862629A (fi) 1987-02-03
ES8801580A1 (es) 1988-02-16
FI86800C (fi) 1999-10-28
GB8519452D0 (en) 1985-09-11
CH668911C1 (de) 2000-05-31
AU5885886A (en) 1987-02-12
KR870001828A (ko) 1987-03-28
ES556291A0 (es) 1988-02-16
YU103586A (en) 1988-04-30
IE861598L (en) 1987-02-02
CN86104283A (zh) 1987-01-28

Similar Documents

Publication Publication Date Title
YU148486A (en) Process for obtaining new insulin analogs
HUT42952A (en) Process for production of infusion solution containing cyproflaxacine
ZA862628B (en) Method for administering insulin
PT83481A (en) Process for preparing low viscosity heteropolysacharides
PT82062A (en) Process for preparing pyridinylimidazolidinone compounds
YU44788B (en) Process for making ready for use solution for injections containing antitumor antracyclic glicoside
YU112486A (en) Process for making silver containing catalyzer
EP0199997A3 (en) Process for preparing diaryl-pentaerythritol
YU44603B (en) Process for obtaining hynolone
GR861004B (en) Process for preparing fluorized benzyltriazol compounds
YU224587A (en) Process for stabilizingwater solution ravitidine
YU44785B (en) Process for synthesys of epipodophylotoxine
HUT42499A (en) Process for preparing new saccharides
PT83154A (en) Process for preparing quinolizinesulphonamides
HUT42766A (en) Process for preparing n-sulfamyl-3-(2-guanidino-thiazolyl-4-methyl-thio)-propionamidine
ZA863454B (en) Process for preparing benzothiazolesulphenamides
PT83654A (en) Process for preparing difluorocyclostatine containing polypeptides
HUT40445A (en) Process for preparing 2-bromo-alpha-ergochristine
HUT43022A (en) Process for preparing monochloro-pinacolone
HUT43039A (en) Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
HUT42769A (en) Process for preparing pyridazodiazepines
HUT40795A (en) Process for preparing fluoro-alkane compounds
GB2171096B (en) Process for preparing pyrone-3-carboxamide compounds
ZA858865B (en) Process for preparing mixtures
HUT42753A (en) Process for preparing aryl-cyanamides